|Day's Range||30.37 - 30.37|
|52 Week Range||26.69 - 30.89|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
AstraZeneca says its cancer drug Imfinzi slowed the growth of lung tumors that are not treatable with surgery, capping off a week that's driven home a clear message about a a promising class of cancer drugs: You puny humans have no idea what is going to happen next.
U.K. stocks were higher Friday, with gains for drug maker AstraZeneca and a lower value in the pound rounding off what’s set to be a winning week for Britain’s blue-chips.
AstraZeneca shares rose to the top of the FTSE 100 leaderboard Friday after the drugmaker said one of its new lung cancer treatments cleared a key hurdle in clinical trials.